{"id":152541,"date":"2023-08-10T11:17:06","date_gmt":"2023-08-10T15:17:06","guid":{"rendered":"https:\/\/44.250.171.167\/?p=152541"},"modified":"2023-08-10T11:17:07","modified_gmt":"2023-08-10T15:17:07","slug":"sanofi-india-ltd-q1fy24-2-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q1fy24-2-rise-in-profits\/","title":{"rendered":"Sanofi India Ltd Q1FY24; 2% rise in Profits"},"content":{"rendered":"\n<p>Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Sanofi India Ltd reported Revenues for Q1FY24 of \u20b9706.00 Crores up from \u20b9699.00 Crore year on year, a rise of 1.0%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY24 of \u20b9539.00 Crores down from \u20b9549.00 Crores year on year, a fall of 1.82%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b9123.00 Crores up 2.5% from \u20b9120.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b953.36, up 2.07% from \u20b952.28 in the same quarter of the previous year.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623.png\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623-839x1024.png\" alt=\"\" class=\"wp-image-152542\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q1FY24 of \u20b9706.00 Crores up from \u20b9699.00 Crore year on year, a rise of 1.0%. Total Expenses for Q1FY24 of \u20b9539.00 Crores down from \u20b9549.00 Crores year on year, a fall of 1.82%. Consolidated [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":152542,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11463,10442,1115],"class_list":["post-152541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-biotech-pharma","tag-cdmo","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-623.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":155973,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q2fy24-16-rise-in-profits\/","url_meta":{"origin":152541,"position":0},"title":"Sanofi India Ltd Q2FY24; 16% rise in Profits","author":"Chirag Gupta","date":"November 9, 2023","format":false,"excerpt":"Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q2FY24 of \u20b9715.00 Crores up from \u20b9692.00 Crore year on year, a rise of 3.32%. Total Expenses for Q2FY24 of \u20b9516.00 Crores down from \u20b9520.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-111.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-111.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-111.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-111.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-111.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-111.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159703,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q3fy24-5-rise-in-profits\/","url_meta":{"origin":152541,"position":1},"title":"Sanofi India Ltd Q3FY24; 5% rise in Profits","author":"Chirag Gupta","date":"March 11, 2024","format":false,"excerpt":"Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q3FY24 of \u20b9694.00 Crores up from \u20b9672.00 Crore year on year, a rise of 3.27%. Total Expenses for Q3FY24 of \u20b9516.00 Crores up from \u20b9515.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-102.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-102.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-102.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-102.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-102.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-102.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167470,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q3fy25-34-fall-in-profits\/","url_meta":{"origin":152541,"position":2},"title":"Sanofi India Ltd Q3FY25; 34% fall in Profits","author":"Chirag Gupta","date":"March 19, 2025","format":false,"excerpt":"Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines. Financial Results: Sanofi India Ltd reported Revenues for Q3FY25 of \u20b9515.00 Crores up from \u20b9469.00 Crore\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161096,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q4fy24-28-fall-in-profits\/","url_meta":{"origin":152541,"position":3},"title":"Sanofi India Ltd Q4FY24; 28% fall in Profits","author":"Chirag Gupta","date":"May 13, 2024","format":false,"excerpt":"Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q4FY24 of \u20b9732.00 Crores down from \u20b9736.00 Crore year on year, a fall of 0.54%. Total Expenses for Q4FY24 of \u20b9524.00 Crores up from \u20b9517.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-91.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-91.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-91.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-91.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-91.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-91.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165923,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-ltd-q2fy25-46-fall-in-profits\/","url_meta":{"origin":152541,"position":4},"title":"Sanofi India Ltd Q2FY25; 46% fall in Profits","author":"Chirag Gupta","date":"December 5, 2024","format":false,"excerpt":"Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines. Financial Results: Sanofi India Ltd reported Revenues for Q2FY25 of \u20b9524.00 Crores up from \u20b9491.00 Crore\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/download-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/download-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/download-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/download-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/download-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/download-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154232,"url":"https:\/\/alphastreet.com\/india\/agro-phos-india-ltd-q1fy24-49-rise-in-revenue\/","url_meta":{"origin":152541,"position":5},"title":"Agro Phos India Ltd Q1FY24; 49% rise in Revenue","author":"Hardik Bhandare","date":"August 17, 2023","format":false,"excerpt":"Incorporated in 2002, Agro Phos India Ltd trades fertilizers and commodities Financial Results: Agro Phos India Ltd reported Revenues for Q1FY24 of \u20b944.98 Crores up from \u20b930.15 Crore year on year, a rise of 49.19%. Total Expenses for Q1FY24 of \u20b946.89 Crores up from \u20b927.37 Crores year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1175.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1175.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1175.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1175.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1175.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1175.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=152541"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152541\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/152542"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=152541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=152541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=152541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}